Harnessing artificial intelligence and machine learning to accelerate structure-based drug discovery for tuberculosis
Year: 2025
Type: editorial
Abstract: 1. The structure-based drug design (SBDD) leverages the structural insights for rational development of small molecules with optimized affinity/selectivity [1,2]. For Mycobacterium tuberculosis (Mt...
Source: Future Medicinal Chemistry
Authors: Zoozeal Thakur, Lalit Bansal, Promod K. Mehta
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: bronze
OpenAlex ID: W7117533965
